|
Volumn 59, Issue 3, 2005, Pages 651-660
|
Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report);Pegylowany interferon alpha-2a z rybawiryna w leczeniu przewlekłego wirusowego zapalenia watroby typu C (raport końcowy z badań).
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
DRUG CARRIER;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG CARRIERS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
RIBAVIRIN;
TREATMENT OUTCOME;
|
EID: 33645983328
PISSN: 00332100
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|